StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
64
This month
1
This year
4
Publishing Date
2024 - 03 - 06
1
2024 - 02 - 27
1
2024 - 01 - 30
1
2023 - 12 - 01
1
2023 - 11 - 07
1
2023 - 11 - 06
1
2023 - 10 - 31
1
2023 - 09 - 07
1
2023 - 08 - 24
1
2023 - 08 - 09
1
2023 - 08 - 08
1
2023 - 08 - 01
1
2023 - 05 - 30
1
2023 - 05 - 11
1
2023 - 05 - 08
1
2023 - 05 - 05
1
2023 - 05 - 04
1
2023 - 05 - 03
1
2023 - 05 - 02
1
2023 - 04 - 03
1
2023 - 03 - 07
1
2023 - 02 - 07
1
2023 - 01 - 31
1
2022 - 11 - 08
2
2022 - 11 - 02
1
2022 - 11 - 01
1
2022 - 10 - 04
1
2022 - 09 - 15
1
2022 - 08 - 15
1
2022 - 08 - 12
1
2022 - 08 - 08
1
2022 - 08 - 05
1
2022 - 08 - 04
1
2022 - 07 - 28
1
2022 - 05 - 11
1
2022 - 05 - 03
1
2022 - 04 - 28
1
2022 - 03 - 30
1
2022 - 03 - 29
2
2022 - 03 - 23
1
2022 - 03 - 01
1
2022 - 02 - 14
1
2022 - 02 - 08
1
2022 - 01 - 12
1
2021 - 12 - 14
1
2021 - 11 - 09
1
2021 - 11 - 02
2
2021 - 09 - 29
1
2021 - 09 - 28
1
2021 - 08 - 30
1
2021 - 08 - 16
1
2021 - 08 - 05
1
2021 - 08 - 04
1
2021 - 07 - 28
1
2021 - 05 - 13
1
2021 - 05 - 04
1
2021 - 04 - 01
1
2021 - 03 - 31
1
2021 - 01 - 27
1
2021 - 01 - 20
1
Sector
Communications
2
Finance
2
Health technology
64
Manufacturing
2
N/a
4
Professional, scientific, and technical services
2
Tags
Abrysvo
1
Antibody
1
Antiviral
1
Atopic dermatitis
1
Bio-nc
2
Biotech-beach
1
Biotechnology
3
Business
1
Candidate
2
China
1
Clinical-trials-phase-ii
3
Clinical-trials-phase-iii
7
Conference
1
Corporation
1
Covid
3
Covid-19
2
Dermatitis
1
Disease
3
Earnings
14
Financial
18
Financial results
3
For
1
Genetown
2
License
2
Lone-star-bio
1
Migraine
1
Money
1
N/a
25
Obesity
1
Order
2
Pharm-country
1
Pharmaceutical
1
Pharmaceuticals
3
Phase 2
4
Phase 2 results
1
Phase 2/3
1
Phase 2b
1
Phase 3
7
Pneumococcal
1
Positive
17
Potential
3
Product-news
1
Report
3
Research
2
Response
1
Results
62
Rheumatoid arthritis
1
Risk
2
Rsv
1
Sars-cov-2
1
Study
2
Tg4001
1
Therapeutics
5
Topline
12
Treatment
2
Trial
11
Ulcerative colitis
4
Update
11
Vaccine
7
Year
3
Entities
Abbott laboratories
1
Abbvie inc.
1
Achieve life sciences, inc.
2
Aerovate therapeutics inc
1
Akero therapeutics, inc.
1
Alnylam pharmaceuticals, inc.
1
Arvinas, inc.
9
Astellas pharma inc
2
Astrazeneca plc
1
Beam therapeutics inc.
5
Biohaven pharmaceutical holding company ltd.
8
Biontech se
15
Calliditas therapeutics ab
1
Deciphera pharmaceuticals, inc.
3
Eli lilly and company
4
Enanta pharmaceuticals, inc.
1
Genmab a/s
2
Gilead sciences, inc.
2
Glaxosmithkline plc
3
Global blood therapeutics, inc.
2
Haleon plc
3
Hercules capital, inc.
1
Incyte corporation
1
Insmed, inc.
1
Ionis pharmaceuticals, inc.
1
Kezar life sciences, inc.
1
Ligand pharmaceuticals incorporated
1
Medies
2
Moderna, inc.
1
Morphosys ag
1
Neurocrine biosciences, inc.
1
Opko health, inc.
2
Orange
2
Pfizer, inc.
64
Pyxis oncology inc
1
Quanterix corporation
1
Sangamo therapeutics, inc.
2
Sanofi
4
Sixth street specialty lending, inc.
1
Spero therapeutics, inc.
1
Tff pharmaceuticals, inc.
1
Thermo fisher scientific inc
1
Vaccinex, inc.
1
Viatris inc.
4
Voyager therapeutics, inc.
4
Symbols
ABBV
92
AEM
51
ALNY
81
AMGN
55
APO
41
ARVL
203
AUY
47
BAM
54
BGNE
52
BMY
73
BNPQF
82
BNPQY
82
BNTX
56
BTG
44
CHRS
48
CYTK
45
DAO
46
ENB
42
FBIO
61
FNCTF
375
FRBA
96
GILD
55
GMAB
48
GOLD
50
INCY
77
IONS
44
JD
43
JKS
43
JNJ
250
LGND
48
LLY
219
LTUM
62
MDT
45
MDWD
54
MEDE
42
MPC
55
MPLX
53
MS
227
NEE
51
NEP
50
NTES
59
NVS
59
NVSEF
44
PAYD
199
PFE
64
PPRUF
89
PPRUY
89
PRVB
46
REGN
89
SBNY
43
SNY
395
SNYNF
317
TAK
71
TEVJF
54
TK
49
TNK
48
TTOO
45
UAN
52
XNCR
42
XYF
104
Exchanges
Nasdaq
43
Nyse
64
Crawled Date
2024 - 03 - 06
1
2024 - 02 - 27
1
2024 - 01 - 30
1
2023 - 12 - 01
1
2023 - 11 - 07
1
2023 - 11 - 06
1
2023 - 10 - 31
1
2023 - 09 - 07
1
2023 - 08 - 24
1
2023 - 08 - 09
1
2023 - 08 - 08
1
2023 - 08 - 01
1
2023 - 05 - 30
1
2023 - 05 - 11
1
2023 - 05 - 08
1
2023 - 05 - 05
1
2023 - 05 - 04
1
2023 - 05 - 03
1
2023 - 05 - 02
1
2023 - 04 - 03
1
2023 - 03 - 07
1
2023 - 02 - 07
1
2023 - 01 - 31
1
2022 - 11 - 08
2
2022 - 11 - 03
1
2022 - 11 - 01
1
2022 - 10 - 04
1
2022 - 09 - 15
1
2022 - 08 - 15
1
2022 - 08 - 12
1
2022 - 08 - 08
1
2022 - 08 - 05
1
2022 - 08 - 04
1
2022 - 07 - 28
1
2022 - 05 - 11
1
2022 - 05 - 03
1
2022 - 04 - 28
1
2022 - 03 - 30
2
2022 - 03 - 29
1
2022 - 03 - 23
1
2022 - 03 - 01
1
2022 - 02 - 14
1
2022 - 02 - 08
1
2022 - 01 - 12
1
2021 - 12 - 14
1
2021 - 11 - 09
1
2021 - 11 - 02
2
2021 - 09 - 29
1
2021 - 09 - 28
1
2021 - 08 - 30
1
2021 - 08 - 16
1
2021 - 08 - 05
1
2021 - 08 - 04
1
2021 - 07 - 28
1
2021 - 05 - 14
1
2021 - 05 - 04
1
2021 - 04 - 01
1
2021 - 03 - 31
1
2021 - 01 - 27
1
2021 - 01 - 20
1
Crawled Time
00:00
1
01:00
5
05:00
1
06:00
1
07:00
1
11:00
13
12:00
17
12:15
1
12:20
4
12:30
4
13:00
5
13:01
1
14:00
2
20:00
1
21:00
4
22:00
2
23:00
1
Source
ir.akerotx.com
1
ir.vaccinex.com
1
ir.voyagertherapeutics.com
2
www.4dpharmaplc.com
1
www.achievelifesciences.com
2
www.biospace.com
39
www.globenewswire.com
14
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
symbols :
Pfe
save search
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published:
2024-04-09
(Crawled : 12:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-1.07%
|
O:
0.73%
H:
2.49%
C:
0.11%
abrysvo
disease
positive
risk
for
rsv
results
study
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
Published:
2024-03-06
(Crawled : 01:00)
- prnewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
0.73%
|
O:
3.14%
H:
1.49%
C:
1.08%
KZR
|
$0.8016
-2.95%
-3.04%
420K
|
Health Technology
|
-22.33%
|
O:
1.94%
H:
0.0%
C:
-1.9%
financial
results
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-02-27
(Crawled : 12:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-3.35%
|
O:
-0.22%
H:
0.29%
C:
-0.85%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
-33.31%
|
O:
0.0%
H:
1.25%
C:
-1.6%
year
update
financial
results
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
Published:
2024-01-30
(Crawled : 12:30)
- biospace.com/
GNMSF
|
News
|
$290.34
3.83%
340
|
Health Technology
|
1.34%
|
O:
2.14%
H:
1.03%
C:
-0.89%
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-16.3%
|
O:
1.76%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-18.36%
|
O:
-3.53%
H:
3.49%
C:
3.4%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-4.4%
|
O:
1.49%
H:
1.72%
C:
-3.12%
GMAB
|
News
|
$28.47
-0.32%
-0.32%
460K
|
Health Technology
|
0.64%
|
O:
0.42%
H:
0.04%
C:
-0.99%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
-17.7%
|
O:
-0.46%
H:
0.79%
C:
0.28%
financial
results
Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity
Published:
2023-12-01
(Crawled : 22:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-13.78%
|
O:
-4.92%
H:
1.48%
C:
-0.21%
obesity
topline
results
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published:
2023-11-07
(Crawled : 12:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-15.75%
|
O:
-0.32%
H:
0.98%
C:
0.55%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
92.2%
|
O:
1.0%
H:
4.2%
C:
4.04%
update
financial
results
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
Published:
2023-11-06
(Crawled : 12:00)
- globenewswire.com
GNMSF
|
News
|
$290.34
3.83%
340
|
Health Technology
|
-2.85%
|
O:
0.24%
H:
3.29%
C:
-1.11%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
3.47%
|
O:
0.16%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-15.96%
|
O:
0.19%
H:
0.29%
C:
-0.45%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
4.09%
|
O:
0.21%
H:
0.0%
C:
0.0%
GMAB
|
News
|
$28.47
-0.32%
-0.32%
460K
|
Health Technology
|
-2.13%
|
O:
0.55%
H:
0.44%
C:
-1.37%
BNTX
|
News
|
$88.18
-0.35%
-0.35%
280K
|
Health Technology
|
-8.03%
|
O:
5.74%
H:
3.18%
C:
-1.55%
update
financial
results
Pfizer Reports Third-Quarter 2023 Results
Published:
2023-10-31
(Crawled : 12:00)
- biospace.com/
HLNCF
|
$4.02
-1.48%
200
|
n/a
|
4.82%
|
O:
2.0%
H:
0.5%
C:
0.5%
HLN
|
$8.35
-0.71%
0.0%
5.2M
|
n/a
|
4.11%
|
O:
0.75%
H:
0.74%
C:
0.12%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
9.18%
|
O:
0.73%
H:
0.0%
C:
-1.7%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-14.01%
|
O:
-0.87%
H:
1.77%
C:
0.91%
BNTX
|
News
|
$88.18
-0.35%
-0.35%
280K
|
Health Technology
|
-5.53%
|
O:
-1.65%
H:
2.78%
C:
2.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
13.12%
|
O:
0.08%
H:
0.41%
C:
0.38%
results
Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate
Published:
2023-09-07
(Crawled : 05:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-23.57%
|
O:
0.29%
H:
0.49%
C:
-0.55%
candidate
disease
report
vaccine
positive
valneva
results
phase 2
Everest Medicines Announces Interim Results for First Half of 2023
Published:
2023-08-24
(Crawled : 01:00)
- prnewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-28.34%
|
O:
-0.5%
H:
0.45%
C:
-0.86%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-12.93%
|
O:
0.27%
H:
1.15%
C:
-1.19%
CALT
|
$18.5
1.65%
1.62%
1.5K
|
Health Technology
|
3.93%
|
O:
-4.72%
H:
0.0%
C:
0.0%
results
Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
Published:
2023-08-09
(Crawled : 13:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-26.29%
|
O:
-0.11%
H:
1.29%
C:
0.67%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-19.82%
|
O:
0.08%
H:
2.08%
C:
1.3%
DCPH
|
$14.6
-0.48%
-0.48%
320K
|
Health Technology
|
12.98%
|
O:
4.95%
H:
2.5%
C:
1.18%
pharmaceuticals
financial
results
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published:
2023-08-08
(Crawled : 11:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-26.37%
|
O:
1.93%
H:
0.0%
C:
-2.01%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
36.61%
|
O:
1.09%
H:
1.29%
C:
0.91%
update
financial
results
Pfizer Reports Second-Quarter 2023 Results
Published:
2023-08-01
(Crawled : 12:00)
- biospace.com/
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
3.8%
|
O:
-1.8%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-27.22%
|
O:
-0.48%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.18
-0.35%
-0.35%
280K
|
Health Technology
|
-17.97%
|
O:
1.14%
H:
0.0%
C:
-1.36%
results
Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial
Published:
2023-05-30
(Crawled : 11:00)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-30.13%
|
O:
-0.64%
H:
0.0%
C:
-0.94%
positive
trial
results
Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update
Published:
2023-05-11
(Crawled : 11:00)
- globenewswire.com
PYXS
|
$4.445
-1.22%
-1.24%
230K
|
Professional, Scientific, and T...
|
49.33%
|
O:
0.67%
H:
6.0%
C:
1.33%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-31.41%
|
O:
-1.83%
H:
0.13%
C:
-0.05%
update
financial
results
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
Published:
2023-05-08
(Crawled : 11:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-31.75%
|
O:
0.1%
H:
0.52%
C:
0.36%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-13.83%
|
O:
0.59%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.18
-0.35%
-0.35%
280K
|
Health Technology
|
-18.76%
|
O:
4.23%
H:
0.0%
C:
-4.4%
update
financial
results
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published:
2023-05-05
(Crawled : 11:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-31.28%
|
O:
0.39%
H:
0.31%
C:
0.29%
ARVN
|
$32.51
-4.38%
-4.58%
470K
|
Health Technology
|
38.41%
|
O:
2.04%
H:
5.9%
C:
5.46%
update
financial
results
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
Published:
2023-05-04
(Crawled : 12:20)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-31.68%
|
O:
-0.73%
H:
0.68%
C:
0.16%
INSM
|
$25.78
2.02%
1.98%
2.5M
|
Health Technology
|
30.35%
|
O:
-1.11%
H:
3.47%
C:
-0.1%
business
update
financial
results
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
Published:
2023-05-03
(Crawled : 12:20)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-32.74%
|
O:
0.36%
H:
0.48%
C:
-1.91%
DCPH
|
$14.6
-0.48%
-0.48%
320K
|
Health Technology
|
2.24%
|
O:
-6.99%
H:
7.22%
C:
4.74%
pharmaceuticals
financial
results
Pfizer Reports First-Quarter 2023 Results
Published:
2023-05-02
(Crawled : 12:20)
- biospace.com/
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-33.0%
|
O:
0.2%
H:
2.1%
C:
-0.59%
BHVN
|
News
0 d
|
$38.72
-2.25%
-0.28%
970K
|
Health Technology
|
185.13%
|
O:
-0.52%
H:
0.44%
C:
-2.29%
BNTX
|
News
|
$88.18
-0.35%
-0.35%
280K
|
Health Technology
|
-21.34%
|
O:
-0.84%
H:
2.03%
C:
0.01%
results
← Previous
1
2
3
4
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.